Ener1 Names Greatbatch to Advisory Committee

Ener1, Inc. has named Mr. Wilson Greatbatch to the company’s independent advisory committee. Greatbatch invented the first successful implantable cardiac pacemaker and the lithium battery technology that is considered today’s international standard for pacemakers and implantable cardioverter defibrillators.

“It is a true honor to have one of America’s greatest inventors and entrepreneurs join our company as a strategic advisor,” said Kevin Fitzgerald, chairman and chief executive officer of Ener1.

Ener1 is pursuing product opportunities for its high-rate lithium batteries in the medical device market, such as pacemakers and defibrillators. The market is estimated at more than $5 billion dollars, with the defibrillator share growing at an estimated 15 to 25% annually. Ener1 believes its lithium battery technologies are well suited for cardiac devices that require safe, highly reliable, long- life power sources with fast charge capabilities. In addition to medical, other markets for the company’s lithium batteries include power tools, industrial equipment, military and automotive.

Greatbatch has more than 300 U.S. and International patents to his credit. He currently serves as chief executive officer of Greatbatch Enterprises Corp., a research and development company that he founded to design and develop components and devices for the medical device industry, as well as electrical energy for future generations. He has received awards from the National Academy of Engineering, Massachusetts Institute of Technology (MIT) (Lifetime Achievement Award) and many other prestigious institutions.